Opening Recap
Market Pulse: Equity sentiment shifted into rally mode as Nike’s surprise beat and raised guidance energized stocks, while Carnival leapt on its own upside surprise. Even Ethereum traders are on edge with more than $10 billion of shorts teetering on a squeeze.
Key Movers: Nike snagged headlines twice—first for a clean beat and then for that audacious “we still have work ahead” caveat. Carnival (NYSE:CUK) shares gapped up ahead of the bell, and Ethereum shorts are at risk of a vicious flip if whales start covering.
Macro & Politics: Novartis just got FDA approval for Rhapsido in chronic spontaneous urticaria, igniting biotech peers. Meanwhile, Congress is gridlocked on funding, threatening a looming shutdown that could spook markets further.
What’s Next: Keep an eye on upcoming earnings reports and Washington’s deadline for the funding bill—volatility is primed to spike before the opening bell.
Unfiltered Market Commentary
Everyone’s chasing the narrative in “$10B in Ethereum shorts at risk – Is a squeeze coming?” from Ambcrypto.com, but few are pricing in the fallout if the D.C. standoff actually triggers a shutdown. That kind of gridlock would freeze economic data flow and could collapse whatever damn momentum we squeeze out on crypto. Traders love the thrill of a digital get-rich leap, but this Times of India report on a “wait-and-see” approach amid shutdown fears shows tokens aren’t bulletproof.
Wall Street is shrugging off the symmetry between Carnival’s gap-up move in “Carnival (NYSE:CUK) Shares Gap Up Following Earnings Beat” (ETF Daily News) and Novartis’s nod in “Novartis announces FDA approval of Rhapsido for treatment of CSU” (Thefly.com). Both are real bottom-line catalysts driving fundamental interest beyond macro noise, yet we’re still fixated on meme-level squeezes and boilerplate trading chatter.
Takeaway? Don’t get swept up in short-squeeze fever when genuine beats and FDA nods are right in front of you. Position for stocks with a hell of a catalyst—lean into names like NVS and CUK, and keep crypto positions tight until Washington sorts its mess. That’s how you stay in the green while the rest are stuck on spin cycle.
📈 Breaking Financial News
Carnival (NYSE:CUK) Shares Gap Up Following Earnings Beat
Carnival Corporation (NYSE:CUK – Get Free Report)’s share price gapped up before the market opened on Monday after the company announced better than expected quarterly earnings. The stock had previously closed at $27.66, but opened at $29.27. Carnival shares …
$10B in Ethereum shorts at risk – Is a squeeze coming?
Ethereum eyes a breakout as bearish momentum fades and whale activity heats up.
Closing Bell Movers: Nike rallies 4% after earnings beat and guidance
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
Novartis announces FDA approval of Rhapsido for treatment of CSU
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
Nike Stock Jumps On Q1 Earnings Beat: ‘We Still Have Work Ahead'
Nike Inc (NYSE:NKE) reported financial results for the first quarter of fiscal 2026 after the market close on Thursday. Here’s a look at the key details from the report.
Check out how NKE shares are doing here.
Q1 Highlights: Nike reported first-quarter reven…
Trump's “New Golden Age” Tech to Create $12 Trillion Boom?
Trump's about to prove everybody wrong. He's been ridiculed for his moves in the trade war… But everything is about to make perfect sense the moment people see Trump's “New Golden Age” tech. Because this little-known technology could ignite a $12 trillion manufacturing revolution… And early investors could see stratospheric gains.
🔍 Market Analysis & Insights
Novartis receives FDA approval for Rhapsido® (remibrutinib), the only oral, targeted BTKi treatment for chronic spontaneous urticaria (CSU)
Ad hoc announcement pursuant to Art. 53 LR Rhapsido helps to inhibit release of histamine and proinflammatory mediators by targeting BTK, offering…
Stocks in news: RBL Bank, Adani Total Gas, IOB, Airtel, Allied Blenders, Man Industries
Markets traded subdued on expiry day, ending almost unchanged amid mixed cues, with rate-sensitive sectors in focus ahead of the RBI policy. RBL Bank partnered with LIC, while Adani Total Gas's CFO resigned. IOB faced an RBI penalty, ICICI Bank received a GST…
Bitcoin wipes $180mln in shorts – So why hasn’t BTC broken out yet?
Does thin liquidity leave BTC vulnerable to another breakdown?
2 Stocks Options Traders Can't Get Enough Of
Options traders are bullish on CoreWeave and struggling DraftKings
Recommendations and Reports: Tularemia Antimicrobial Treatment and Prophylaxis: CDC Recommendations for Naturally Acquired Infections and Bioterrorism Response – United States, 2025
This report describes the 2025 recommendations for tularemia antimicrobial treatment and prophylaxis. This updates the 2001 recommendations for treatment of naturally acquired tularemia as well as tularemia occurring as a result of a bioterrorism attack.
This “awesome resource” could power America for 30,000 years…
We sent one of our smartest researchers…. a consultant who's worked for the likes of J.P. Morgan and Citicorp… into the middle of the Utah desert with a film crew.Why? So he could lead an investigation into a radical new kind of energy that's so abundant, the Dept. of Energy says it could meet America's power needs for the next 2 million years. It's got nothing to do with wind, solar, nuclear, oil or gas. This could be huge for early stakeholders – click here for details.
💰 Investment Opportunities
Celcuity Inc. (CELC)’s FDA NDA for Gedatolisib Accepted Under RTOR, Accelerating Review
We recently compiled a list of the 12 Best Performing Healthcare Stocks to Buy Right Now. Celcuity Inc. (NASDAQ:CELC) is one of them. Celcuity Inc. is a…
Insmed Incorporated (INSM) Rallies After FDA Approves Brinsupri, Shares Jump 9%
We recently compiled a list of the 12 Best Performing Healthcare Stocks to Buy Right Now. Insmed Incorporated is one of them. Insmed Incorporated…
Dear AppLovin Stock Fans, Mark Your Calendars for October 1
The soon-to-be-launched tool for non-gaming advertisers has led to a significant rally in the stock.
Sequana Medical’s alfapump® System Featured in Presentation at 2025 Portal Intervention Symposium
, Sept. 30, 2025 (GLOBE NEWSWIRE) — Dr. Rahul Patel of Icahn School of Medicine at Mount Sinai presented “alfapump®: Totally Implantable Peritoneal Drain Pump with Urinary Bladder Drainage”
US stock market today: Dow Jones, S&P 500, and Nasdaq fall as investors take “wait-and-see” approach amid government shutdown fears
U.S. stocks fell slightly today as worries over a possible government shutdown grew. Investors are concerned that the shutdown could delay important economic data, including jobs and inflation reports. These reports are crucial for the Federal Reserve to deci…
Oil Jumps 8.5% on Middle East Crisis
Oil surged 8.5% to $74/barrel after Israel's Iran strike – biggest jump since 2022. Experts predict $100+ oil if conflict spreads. Don't chase volatile oil stocks. See Marc's safer alternative here.